Brain health startup to join SpinUp as first AbbVie Biotech Innovators Award winner

A man in a white lab coat gestures while speaking to a group of people also wearing lab coats and safety goggles inside a laboratory.

A biotech startup tackling brain diseases is joining University of Toronto Mississauga’s SpinUp incubator as the inaugural winner of the AbbVie Biotech Innovators Award.

Neuropeutics Inc., founded by U of T researchers, received the new national prize created by AbbVie and SpinUp to support early-stage ventures with the potential to deliver breakthrough therapies.

“We are delighted to have this opportunity to collaborate with a global biopharmaceutical company such as AbbVie, and the University of Toronto’s SpinUp, to advance Neuropeutics’ therapeutic research and development across multiple neurodegenerative diseases,” said Neuropeutics CEO Marc Shenouda.

The startup will receive a year of free lab space and mentorship from AbbVie’s scientific and business leaders, along with access to SpinUp’s advanced equipment, research community and entrepreneurial programming.

The award was presented during an event marking one year of SpinUp, U of T’s first wet lab incubator, during a daylong showcase that also announced the continuation of SpinUp’s collaboration with Merck to support promising Canadian ventures.

Dignitaries pose at the SpinUp first anniversary event.
From left to right: Christina Vorvis, Raquel De Souza, Marc Shenouda, Arima Ventin, Stephanie Sauvageau, Hayley McKay, France Gagnon. 

Selected from a national pool of applicants, Neuropeutics is the latest venture to join SpinUp’s growing community of startups working to translate promising research into real-world solutions.

Co-founded by Temerty Faculty of Medicine researchers Shenouda and Professor Janice Robertson, Neuropeutics is developing small-molecule drugs that prevent and reverse the buildup of toxic proteins in the brain — a process linked to conditions such as ALS, Alzheimer’s and Parkinson’s.

“At Neuropeutics, we are committed to developing targeted therapies to extend neurodegenerative disease patients’ survival and improve their quality of life,” said Shenouda, the company’s CEO. “This award allows us to pursue that mission with greater momentum.”

Neuropeutics’ lead compound, JRMS-22, targets TDP-43, a protein that becomes toxic when it misfolds and clumps in the brain. The company’s approach aims to prevent and even reverse this aggregation, offering a potential new pathway for treatment for several neurodegenerative diseases. 

The research underpinning this work was conducted at U of T’s Tanz Centre for Research in Neurodegenerative Diseases, where Robertson is a senior researcher and Shenouda is a postdoctoral fellow.

SpinUp will soon grow its ecosystem of biotech innovators with the return of the Blue Ticket competition, offered in partnership with Merck.

The program, which provides lab space, mentorship, and entrepreneurial support, was awarded last year to Atorvia, a woman-led startup focused on metabolic health. Applications for this year’s competition are open until July 14.

The University of Toronto Mississauga’s SpinUp incubator marked its first anniversary by awarding a major national biotech prize and announcing a renewed partnership to fuel the next wave of Canadian life sciences startups.

Raquel De Souza, UTM’s director of partnerships and innovation, says partners like AbbVie and Merck are essential to SpinUp’s mission to turn scientific innovation into investor-ready ventures.

“While Canada is a global leader in life sciences research, more specialized lab infrastructure and related entrepreneurial supports are urgently needed to help scientists turn their discoveries into impactful commercial innovations,” she said. 

“SpinUp is helping address these challenges by providing affordable access to a brand new, state-of-the-art research facility, robust entrepreneurship programming and world-leading research talent at the university.”

Three students study plants in a dark lab

Discover Life Sciences at U of T Mississauga

Study life in all its forms. With a Life Sciences degree, you’ll explore everything from cells to ecosystems — and apply that knowledge to tackle challenges in health, sustainability and more.